Given that inhibitors of RNR activity modulated ara‐C toxicity in a SAMHD1‐dependent manner, we next evaluated whether expression levels of RNR genes impact the survival of AML patients treated with ara‐C. This evidence concerns the gene NR2E3 and acute myeloid leukemia.